mechlorethamine has been researched along with Hematologic Malignancies in 4 studies
nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Lin, M | 1 |
Guo, W | 1 |
Zhang, Z | 1 |
Zhou, Y | 1 |
Chen, J | 1 |
Wang, T | 1 |
Zhong, X | 1 |
Lu, Y | 1 |
Yang, Q | 1 |
Wei, Q | 1 |
Han, M | 1 |
Xu, D | 1 |
Gao, J | 1 |
HORLIN, W | 1 |
SCHMITT, W | 1 |
Ogawa, M | 1 |
Gandhi, MK | 1 |
Jestice, K | 1 |
Scott, MA | 1 |
Bloxham, D | 1 |
Bass, G | 1 |
Marcus, RE | 1 |
1 review available for mechlorethamine and Hematologic Malignancies
Article | Year |
---|---|
[Hematologic tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dacarbazine | 2003 |
3 other studies available for mechlorethamine and Hematologic Malignancies
Article | Year |
---|---|
Reduced Toxicity of Liposomal Nitrogen Mustard Prodrug Formulation Activated by an Intracellular ROS Feedback Mechanism in Hematological Neoplasm Models.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Survival; Disease Models, Animal; Drug Compounding; | 2020 |
[Treatment of hematologic neoplasms with nitrogen oxide mustards].
Topics: Hematologic Neoplasms; Hodgkin Disease; Leukemia; Lymphoma; Mechlorethamine; Mustard Plant; Nitrogen | 1957 |
The minimum CD34 threshold depends on prior chemotherapy in autologous peripheral blood stem cell recipients.
Topics: Adolescent; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; | 1999 |